261 related articles for article (PubMed ID: 21818819)
41. Efficacy of the ViziLite system in the identification of oral lesions.
Oh ES; Laskin DM
J Oral Maxillofac Surg; 2007 Mar; 65(3):424-6. PubMed ID: 17307587
[TBL] [Abstract][Full Text] [Related]
42. Autofluorescence and Diagnostic Accuracy of Lesions of Oral Mucosa: A Pilot Study.
Jané-Salas E; Blanco-Carrión A; Jover-Armengol L; López-López J
Braz Dent J; 2015; 26(6):580-6. PubMed ID: 26963199
[TBL] [Abstract][Full Text] [Related]
43. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions.
Güneri P; Epstein JB; Kaya A; Veral A; Kazandı A; Boyacioglu H
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):155-61. PubMed ID: 21112183
[TBL] [Abstract][Full Text] [Related]
44. Cytologic and DNA-cytometric very early diagnosis of oral cancer.
Maraki D; Becker J; Boecking A
J Oral Pathol Med; 2004 Aug; 33(7):398-404. PubMed ID: 15250831
[TBL] [Abstract][Full Text] [Related]
45. Fluorescence visualization efficacy for detecting oral lesions more prone to be dysplastic and potentially malignant disorders: a pilot study.
Simonato LE; Tomo S; Miyahara GI; Navarro RS; Villaverde AGJB
Photodiagnosis Photodyn Ther; 2017 Mar; 17():1-4. PubMed ID: 27989864
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of Autofluorescence Imaging as an Adjunctive Technique for Examination and Detection of Oral Potentially Malignant Disorders: A Systematic Review.
Awan KH; Patil S
J Contemp Dent Pract; 2015 Sep; 16(9):744-9. PubMed ID: 26522601
[TBL] [Abstract][Full Text] [Related]
47. Velscope guided oral cancer screening: A ray of hope in early oral cancer diagnosis.
Vibhute NA; Jagtap SV; Patil SV
J Oral Maxillofac Pathol; 2021; 25(3):548-549. PubMed ID: 35281151
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of optical fluorescence imaging in identification and triaging of oral potentially malignant disorders: A study of VELscope in the LESIONS programme.
Farah CS; Dost F; Do L
J Oral Pathol Med; 2019 Aug; 48(7):581-587. PubMed ID: 31172574
[TBL] [Abstract][Full Text] [Related]
49. Potential role of autofluorescence imaging in determining biopsy of oral potentially malignant disorders: A large prospective diagnostic study.
Shi L; Li C; Shen X; Zhou Z; Liu W; Tang G
Oral Oncol; 2019 Nov; 98():176-179. PubMed ID: 31416690
[TBL] [Abstract][Full Text] [Related]
50. Assessment of a decision making protocol to improve the efficacy of VELscope™ in general dental practice: a prospective evaluation.
Bhatia N; Matias MA; Farah CS
Oral Oncol; 2014 Oct; 50(10):1012-9. PubMed ID: 25096826
[TBL] [Abstract][Full Text] [Related]
51. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology.
De Veld DC; Witjes MJ; Sterenborg HJ; Roodenburg JL
Oral Oncol; 2005 Feb; 41(2):117-31. PubMed ID: 15695112
[TBL] [Abstract][Full Text] [Related]
52. Comparative evaluation of autofluorescence imaging and histopathological investigation for oral potentially malignant disorders in Taiwan.
Chiang TE; Lin YC; Li YH; Wu CT; Kuo CS; Chen YW
Clin Oral Investig; 2019 May; 23(5):2395-2402. PubMed ID: 30302607
[TBL] [Abstract][Full Text] [Related]
53. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
54. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
55. Novel quantitative analysis of autofluorescence images for oral cancer screening.
Huang TT; Huang JS; Wang YY; Chen KC; Wong TY; Chen YC; Wu CW; Chan LP; Lin YC; Kao YH; Nioka S; Yuan SF; Chung PC
Oral Oncol; 2017 May; 68():20-26. PubMed ID: 28438288
[TBL] [Abstract][Full Text] [Related]
56. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases.
Scheifele C; Schmidt-Westhausen AM; Dietrich T; Reichart PA
Oral Oncol; 2004 Sep; 40(8):824-8. PubMed ID: 15288838
[TBL] [Abstract][Full Text] [Related]
57. Laser-induced autofluorescence spectral ratio reference standard for early discrimination of oral cancer.
Mallia RJ; Thomas SS; Mathews A; Kumar R; Sebastian P; Madhavan J; Subhash N
Cancer; 2008 Apr; 112(7):1503-12. PubMed ID: 18260154
[TBL] [Abstract][Full Text] [Related]
58. Time-resolved autofluorescence spectroscopy for classifying normal and premalignant oral tissues.
Chen HM; Chiang CP; You C; Hsiao TC; Wang CY
Lasers Surg Med; 2005 Jul; 37(1):37-45. PubMed ID: 15954122
[TBL] [Abstract][Full Text] [Related]
59. Screening for oral precancer with noninvasive genetic cytology.
Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
[TBL] [Abstract][Full Text] [Related]
60. [A white lesion of the oral mucosa: leukoplakia?].
Gielkens PF; de Visscher JG; van der Waal I
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2197-201. PubMed ID: 14640054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
